Literature DB >> 25813583

Alteration of the bone tissue material properties in type 1 diabetes mellitus: A Fourier transform infrared microspectroscopy study.

Aleksandra Mieczkowska1, Sity Aishah Mansur2, Nigel Irwin3, Peter R Flatt3, Daniel Chappard4, Guillaume Mabilleau5.   

Abstract

Type 1 diabetes mellitus (T1DM) is a severe disorder characterized by hyperglycemia and hypoinsulinemia. A higher occurrence of bone fractures has been reported in T1DM, and although bone mineral density is reduced in this disorder, it is also thought that bone quality may be altered in this chronic pathology. Vibrational microscopies such as Fourier transform infrared microspectroscopy (FTIRM) represent an interesting approach to study bone quality as they allow investigation of the collagen and mineral compartment of the extracellular matrix in a specific bone location. However, as spectral feature arising from the mineral may overlap with those of the organic component, the demineralization of bone sections should be performed for a full investigation of the organic matrix. The aims of the present study were to (i) develop a new approach, based on the demineralization of thin bone tissue section to allow a better characterization of the bone organic component by FTIRM, (ii) to validate collagen glycation and collagen integrity in bone tissue and (iii) to better understand what alterations of tissue material properties in newly forming bone occur in T1DM. The streptozotocin-injected mouse (150 mg/kg body weight, injected at 8 weeks old) was used as T1DM model. Animals were randomly allocated to control (n = 8) or diabetic (n = 10) groups and were sacrificed 4 weeks post-STZ injection. Bones were collected at necropsy, embedded in polymethylmethacrylate and sectioned prior to examination by FTIRM. FTIRM collagen parameters were collagen maturity (area ratio between 1660 and 1690 cm(-1) subbands), collagen glycation (area ratio between the 1032 cm(-1) subband and amide I) and collagen integrity (area ratio between the 1338 cm(-1) subband and amide II). No significant differences in the mineral compartment of the bone matrix could be observed between controls and STZ-injected animals. On the other hand, as compared with controls, STZ-injected animals presented with significant higher value for collagen maturity (17%, p = 0.0048) and collagen glycation (99%, p = 0.0121), while collagen integrity was significantly lower by 170% (p = 0.0121). This study demonstrated the profound effect of early T1DM on the organic compartment of the bone matrix in newly forming bone. Further studies in humans are required to ascertain whether T1DM also lead to similar effect on the quality of the bone matrix.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Collagen glycation; Collagen integrity; Fourier transform infrared microspectroscopy; Type 1 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 25813583     DOI: 10.1016/j.bone.2015.03.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Pulsed electromagnetic fields preserve bone architecture and mechanical properties and stimulate porous implant osseointegration by promoting bone anabolism in type 1 diabetic rabbits.

Authors:  J Cai; W Li; T Sun; X Li; E Luo; D Jing
Journal:  Osteoporos Int       Date:  2018-03-09       Impact factor: 4.507

Review 2.  Mouse models of type 1 diabetes and their use in skeletal research.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Kathryn M Thrailkill
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-24       Impact factor: 3.626

3.  Diabetes impairs fracture healing through disruption of cilia formation in osteoblasts.

Authors:  Zahra Chinipardaz; Min Liu; Dana Graves; Shuying Yang
Journal:  Bone       Date:  2021-09-09       Impact factor: 4.626

Review 4.  Effects of Diabetes on Bone Material Properties.

Authors:  Sashank Lekkala; Erik A Taylor; Heather B Hunt; Eve Donnelly
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 5.  Proglucagon-Derived Peptides as Therapeutics.

Authors:  Ryan A Lafferty; Finbarr P M O'Harte; Nigel Irwin; Victor A Gault; Peter R Flatt
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

6.  Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice.

Authors:  Mishaela R Rubin; Eleftherios P Paschalis; Atharva Poundarik; Gyna E Sroga; Donald J McMahon; Sonja Gamsjaeger; Klaus Klaushofer; Deepak Vashishth
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

Review 7.  Diabetes and Bone Fragility.

Authors:  Camila Romero-Díaz; Daniela Duarte-Montero; Sebastián A Gutiérrez-Romero; Carlos O Mendivil
Journal:  Diabetes Ther       Date:  2020-11-13       Impact factor: 3.595

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.